Substituted 4-biarylbutyric or 5-blarylpentanoic acids and derivatives matrix metalloprotease inhibitors

Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula (T)xA-B-D-E-G, wherein A and B are aryl or heteroaryl rings; each T is a substituent group; x is 0, 1, or 2; the group D represents formulas, the group E represents a two or three carbon chain bearing one to three substituent groups which are independent or are involved in ring formaiton, possible structures being shown in the text and claims; and the group G represents -PO3H2, -M, formulas, in which M represents -CO2H, -CON(R11)2, or -CO2R12; and R13 represents any of the side chains of the 19 noncyclic naturally occurring amino acids, and include pharmaceutically acceptable salts thereof.